State of Wyoming’s Adaptive Biotechnologies ADPT Stock Holding History

State of Wyoming’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$285K	Sell	13,274 -9,295	-41%	-$142K	0.03%	731
2026 Q1	$313K	Sell	22,569 -10,888	-33%	-$173K	0.04%	645
2025 Q4	$543K	Sell	33,457 -5,113	-13%	-$83.4K	0.06%	326
2025 Q3	$577K	Buy	38,570 +3,283	+9%	+$40K	0.07%	247
2025 Q2	$411K	Buy	+35,287	New	+$321K	0.05%	412
2023 Q1	–	Sell	-3,468	Closed	-$26.5K	–	1573
2022 Q4	$26.5K	Sell	3,468 -2,209	-39%	-$17.2K	0.01%	1291
2022 Q3	$40K	Buy	+5,677	New	+$53.5K	0.02%	1090
2021 Q2	–	Sell	-15	Closed	-$1K	–	1168
2021 Q1	$1K	Buy	+15	New	+$812	﹤0.01%	479

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State of Wyoming's ADPT Position: Q2 2026 in Review

State of Wyoming reduced its Adaptive Biotechnologies (ADPT) stake by 41% in Q2 2026, selling an estimated $142K and leaving 13,274 shares worth $285K. The position accounts for 0.03% of the portfolio, ranked #731.

State of Wyoming first reported a position in ADPT in Q1 2021 and has held it in 8 quarters since. The position peaked at $577K in Q3 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

State of Wyoming held 13,274 shares of Adaptive Biotechnologies worth $285K as of Q2 2026.
State of Wyoming sold 9,295 Adaptive Biotechnologies shares in Q2 2026, an estimated $142K.
Adaptive Biotechnologies made up 0.03% of State of Wyoming's portfolio in Q2 2026, its #731 holding.
State of Wyoming first reported a position in Adaptive Biotechnologies in Q1 2021 and has held it in 8 quarters since.
State of Wyoming's Adaptive Biotechnologies position peaked at $577K in Q3 2025.
300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.